Page 263 - Read Online
P. 263
Cao Cancer Evo-Dev
2. Ewald PW. 99th Dahlem conference on infection, inflammation and Genet 2009;41:591-5.
chronic inflammatory disorders: symbionts and immunopathology 19. Guo X, Zhang Y, Li J, Ma J, Wei Z, Tan W, O’Brien SJ. Strong
in chronic diseases: insights from evolution. Clin Exp Immunol influence of human leukocyte antigen (HLA)-DP gene variants on
2010;160:27-34. development of persistent chronic hepatitis B virus carriers in the Han
3. Du Y, Han X, Ding YB, Yin JH, Cao GW. Prediction and prophylaxis Chinese population. Hepatology 2011;53:422-8.
of hepatocellular carcinoma occurrence and postoperative recurrence 20. Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, Foo JN, McLaren PJ,
in chronic hepatitis B virus-infected subjects. World J Gastroenterol Li Z, Yang J, Shen F, Liu L, Yang J, Li S, Pan S, Wang Y, Li W,
2016;22:6565-72. Zhai X, Zhou B, Shi L, Chen X, Chu M, Yan Y, Wang J, Cheng
4. Cho JY, Paik YH, Sohn W, Cho HC, Gwak GY, Choi MS, Lee JH, S, Shen J, Jia W, Liu J, Yang J, Wen Z, Li A, Zhang Y, Zhang G,
Koh KC, Paik SW, Yoo BC. Patients with chronic hepatitis B treated Luo X, Qin H, Chen M, Wang H, Jin L, Lin D, Shen H, He L, de
with oral antiviral therapy retain a higher risk for HCC compared with Bakker PI, Wang H, Zeng YX, Wu M, Hu Z, Shi Y, Liu J, Zhou W.
patients with inactive stage disease. Gut 2014;63:1943-50. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for
5. Fung AKY, Chong CCN, Lee KF, Wong J, Cheung YS, Fong AKW, hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS
Lai PBS. Outcomes of emergency and interval hepatectomy for Genet 2012;8:e1002791.
ruptured resectable hepatocellular carcinoma: a single tertiary referral 21. Hu Z, Liu Y, Zhai X, Dai J, Jin G, Wang L, Zhu L, Yang Y, Liu J,
centre experience. Hepatoma Res 2017;3:196-204. Chu M, Wen J, Xie K, Du G, Wang Q, Zhou Y, Cao M, Liu L, He Y,
6. Chok KSH. Surgical strategy for huge and advanced hepatocellular Wang Y, Zhou G, Jia W, Lu J, Li S, Liu J, Yang H, Shi Y, Zhou W,
carcinoma in Hong Kong. Hepatoma Res 2017;3:189-95. Shen H. New loci associated with chronic hepatitis B virus infection
7. Sarkar J, DeLeon T, Wong LL. MELD score and AST-to-platelet in Han Chinese. Nat Genet 2013;45:1499-503.
ratio index predict long-term survival in patients with a small 22. Zhu M, Dai J, Wang C, Wang Y, Qin N, Ma H, Song C, Zhai X,
hepatocellular carcinoma following non-transplant therapies: a pilot Yang Y, Liu J, Liu L, Li S, Liu J, Yang H, Zhu F, Shi Y, Shen H,
study. Hepatoma Res 2017;3:79-85. Jin G, Zhou W, Hu Z. Fine mapping the MHC region identified four
8. Chen L, Zhang Q, Chang W, Du Y, Zhang H, Cao G. Viral and independent variants modifying susceptibility to chronic hepatitis B in
host inflammation-related factors that can predict the prognosis of Han Chinese. Hum Mol Genet 2016;25:1225-32.
hepatocellular carcinoma. Eur J Cancer 2012;48:1977-87. 23. Png E, Thalamuthu A, Ong RT, Snippe H, Boland GJ, Seielstad M.
9. Liu WB, Yang F, Shao DY, Cao GW. Novel predictive and prognostic A genome-wide association study of hepatitis B vaccine response in
strategies of hepatitis B virus related hepatocellular carcinoma. an Indonesian population reveals multiple independent risk variants in
Hepatoma Res 2016;2:331-40. the HLA region. Hum Mol Genet 2011;20:3893-8.
10. Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory 24. Tan W, Xia J, Dan Y, Li M, Lin S, Pan X, Wang H, Tang Y, Liu N,
pathways for prevention and therapy of cancer: short-term friend, Tan S, Liu M, He W, Zhang W, Mao Q, Wang Y, Deng G. Genome-
long-term foe. Clin Cancer Res 2009;15:425-30. wide association study identifies HLA-DR variants conferring
11. He G, Karin M. NF-κB and STAT3 - key players in liver inflammation risk of HBV-related acute-on-chronic liver failure. Gut 2017; pii:
and cancer. Cell Res 2011;21:159-68. gutjnl-2016-313035.
12. Li Z, Hou X, Cao G. Is mother-to-infant transmission the most 25. Jiang DK, Ma XP, Wu X, Peng L, Yin J, Dan Y, Huang HX, Ding DL,
important factor for persistent HBV infection? Emerg Microbes Infect Zhang LY, Shi Z, Zhang P, Yu H, Sun J, Lilly Zheng S, Deng G, Xu
2015;4:e30. J, Liu Y, Guo J, Cao G, Yu L. Genetic variations in STAT4,C2,HLA-
13. Zhang HW, Yin JH, Li YT, Li CZ, Ren H, Gu CY, Wu HY, Liang DRB1 and HLA-DQ associated with risk of hepatitis B virus-related
XS, Zhang P, Zhao JF, Tan XJ, Lu W, Schaefer S, Cao GW. Risk liver cirrhosis. Sci Rep 2015;5:16278.
factors for acute hepatitis B and its progression to chronic hepatitis in 26. Yu L, Cheng YJ, Cheng ML, Yao YM, Zhang Q, Zhao XK, Liu HJ,
Shanghai, China. Gut 2008;57:1713-20. Hu YX, Mu M, Wang B, Yang GZ, Zhu LL, Zhang S. Quantitative
14. Yin J, Zhang H, He Y, Xie J, Liu S, Chang W, Tan X, Gu C, Lu W, assessment of common genetic variations in HLA-DP with hepatitis B
Wang H, Bi S, Cui F, Liang X, Schaefer S, Cao G. Distribution and virus infection, clearance and hepatocellular carcinoma development.
hepatocellular carcinoma-related viral properties of hepatitis B virus Sci Rep 2015;5:14933.
genotypes in Mainland China: a community-based study. Cancer 27. Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, Ren WH, Long XD,
Epidemiol Biomarkers Prev 2010;19:777-86. Zhang H, Ma XP, Wang Z, Jiang W, Chen TY, Gao Y, Sun LD, Long
15. Yin JH, Zhao J, Zhang HW, Xie JX, Li WP, Xu GZ, Shen J, Dong JR, Huang HX, Wang D, Yu H, Zhang P, Tang LS, Peng B, Cai H, Liu
HJ, Zhang J, Wang L, Han JK, Wang HY, Cao GW. HBV genotype TT, Zhou P, Liu F, Lin X, Tao S, Wan B, Sai-Yin HX, Qin LX, Yin J,
C is independently associated with cirrhosis in community-based Liu L, Wu C, Pei Y, Zhou YF, Zhai Y, Lu PX, Tan A, Zuo XB, Fan J,
population. World J Gastroenterol 2010;16:379-83. Chang J, Gu X, Wang NJ, Li Y, Liu YK, Zhai K, Zhang H, Hu Z, Liu
16. Chan HL, Wong GL, Tse CH, Chim AM, Yiu KK, Chan HY, Sung J, Yi Q, Xiang Y, Shi R, Ding Q, Zheng W, Shu XO, Mo Z, Shugart
JJ, Wong VW. Hepatitis B virus genotype C is associated with more YY, Zhang XJ, Zhou G, Shen H, Zheng SL, Xu J, Yu L. Genetic
severe liver fibrosis than genotype B. Clin Gastroenterol Hepatol variants in STAT4 and HLA-DQ genes confer risk of hepatitis B
2009;7:1361-6. virus-related hepatocellular carcinoma. Nat Genet 2013;45:72-5.
17. Yin J, Zhang H, Li C, Gao C, He Y, Zhai Y, Zhang P, Xu L, Tan 28. Schaefer S. Hepatitis B virus taxonomy and hepatitis B virus
X, Chen J, Cheng S, Schaefer S, Cao G. Role of hepatitis B virus genotypes. World J Gastroenterol 2007;13:14-21.
genotype mixture, subgenotypes C2 and B2 on hepatocellular 29. Yin J, Xie J, Liu S, Zhang H, Han L, Lu W, Shen Q, Xu G, Dong H,
carcinoma: compared with chronic hepatitis B and asymptomatic Shen J, Zhang J, Han J, Wang L, Liu Y, Wang F, Zhao J, Zhang Q,
carrier state in the same area. Carcinogenesis 2008;29:1685-91. Ni W, Wang H, Cao G. Association between the various mutations in
18. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi viral core promoter region to different stages of hepatitis B, ranging
A, Hosono N, Kubo M, Tsunoda T, Kamatani N, Kumada H, of asymptomatic carrier state to hepatocellular carcinoma. Am J
Puseenam A, Sura T, Daigo Y, Chayama K, Chantratita W, Nakamura Gastroenterol 2011;106:81-92.
Y, Matsuda K.A genome-wide association study identifies variants in 30. Yin J, Xie J, Zhang H, Shen Q, Han L, Lu W, Han Y, Li C, Ni W,
the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Wang H, Cao G.Significant association of different preS mutations
Hepatoma Research ¦ Volume 3 ¦ October 27, 2017 255